GENE ONLINE|News &
Opinion
Blog

2018-05-15|

May 14, 2005: Piggybac as a Genetic Manipulation Tool for Analyzing Vertebrates, Patent Application Submitted to WIPO

by GeneOnline
Share To

The PiggyBac (PB) transposon is a mobile genetic element that can transpose between vectors and chromosomes via a “cut and paste” mechanism, and thus PiggyBac is an important tool related to transgenic technique. One specific technique using Piggybac as a tool for genetic manipulation and analysis in vertebrates was previously granted by the patent offices in the US, Europe, Canada, Japan, and China. On May 14, 2005, the inventors submitted a patent application to the World Intellectual Property Organization (WIPO) for this technique. Using PB transposon to transfer targeted gene fragment from vector into chromosome can effectively transplant targeted gene into the gene of certain organisms. In addition, PiggyBac technology is also equipped with a unique reversible characteristic.

Reference
http://europepmc.org/patents/PAT/CA2608481
https://en.wikipedia.org/wiki/PiggyBac_Transposon_System

Image Source
https://www.systembio.com/products/gene-expression-systems/piggybac-transposon/

©www.geneonline.com All rights reserved. Collaborate with us: service@geneonlineasia.com
Related Post
US Court Rules Novartis Blockbuster Multiple Sclerosis Drug’s Patent Invalid
2022-06-22
Bristol Myers Squibb Requests $1.2 Billion Patent Revival From Supreme Court
2022-06-17
Illumina to Pay BGI $333M Following Infringement Case
2022-05-09
LATEST
Takeda, Astellas, and Sumitomo Mitsui Banking Declare Agreement For Early Drug Discovery Program Incubation in Joint Venture
2024-04-23
Ochre Bio Announces Partnership with Boehringer Ingelheim to Develop Novel Regenerative Treatments for Patients with Advanced Liver Disease
2024-04-22
Earth Day Awareness: Hospitals Embrace Sustainability Efforts
2024-04-22
WHO Raises Alarm: Bird Flu Threat to Humans an ‘Enormous Concern’
2024-04-19
The Legal Battlefield of Weight-Loss Drugs: Eli Lilly and Novo Nordisk on the Defensive
2024-04-18
Pharmacogenomics in Asia-Pacific: Nalagenetics CEO Levana Sani Offers Insights and Strategies
2024-04-17
Rice University Engineers Develop Miniature Brain Stimulator for Safer and Less-invasive Neuromodulation
2024-04-17
EVENT
2024-04-27
2024 Biomedical Final Pitch Competition
Room DA1620, Dana Building, Dana-Farber Cancer Institute, 99 Jimmy Fund Way, Boston, MA 02115
Scroll to Top